Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_assertion type Assertion NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_head.
- NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_assertion wasGeneratedBy ECO_0000203 NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_provenance.
- NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_assertion wasDerivedFrom befree-2016 NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_provenance.
- NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_assertion SIO_000772 19890372 NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_provenance.
- NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_assertion evidence source_evidence_literature NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_provenance.
- NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_assertion description "[Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773898.RA_UkSyvc5vkXA0TDJfYj-AjdmJMvSL17H4wOG1DvRRko130_provenance.